Human Herpesvirus 8 (HHV-8/KSHV) and Hematologic Malignancies

Reviews in Clinical and Experimental Hematology

Volumn 7, Issue 4, 2003, Pages 375-405

  Malnati, Mauro S ^a   Dagna, Lorenzo ^b   Ponzoni, Maurilio ^a   Lusso, Paolo ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BONE MARROW CELL; HEMATOLOGIC MALIGNANCY; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLASTIC LYMPHOMA; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE MYELOMA; NONHUMAN; PREVALENCE; PRIMARY EFFUSION LYMPHOMA; REVIEW; VIRUS ISOLATION; VIRUS ONCOGENE;

CELL TRANSFORMATION, VIRAL; GENES, VIRAL; GIANT LYMPH NODE HYPERPLASIA; HEMATOLOGIC NEOPLASMS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, LARGE-CELL; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; LYMPHOPROLIFERATIVE DISORDERS; OPEN READING FRAMES; SEROEPIDEMIOLOGIC STUDIES; VIRAL PROTEINS;

EID: 1342304223     PISSN: 11270020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (241)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266: 1865-1869, 1994.
2. Boshoff C and Weiss RA. Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res, 75: 57-86, 1998.
3. Schulz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol, 79 (Pt 7): 1573-1591, 1998.
4. Neipel F and Fleckenstein B. The role of HHV-8 in Kaposi's sarcoma. Semin Cancer Biol, 9: 151-164, 1999.
5. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med, 2: 925-928, 1996.
6. Lennette ET, Blackbourn DJ and Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet, 348: 858-861, 1996.
7. Rezza G, Lennette ET, Giuliani M, et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer, 77: 361-365, 1998.
8. Whitby D, Luppi M, Barozzi P, et al. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst, 90: 395-397, 1998.
9. Gallo RC. The enigmas of Kaposi's sarcoma. Science, 282: 1837-9, 1998.
10. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med, 332: 1186-1191, 1995.
11. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 86: 1276-1280, 1995.
12. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol, 94: 533-543, 1996.
13. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia, 10: 1358-1362, 1996.
14. Gessain A, Briere J, Angelin-Duclos C, et al. Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas. Leukemia, 11: 266-272, 1997.
15. Karcher DS and Alkan S. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol, 28: 801-808, 1997.
16. Gessain A, Sudaka A, Briere J, et al. Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood, 87: 414-416, 1996.
17. Gaidano G, Pastore C, Gloghini A, et al. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. Aids, 10: 941-949, 1996.
18. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science, 276: 1851-1854, 1997.
19. Ablashi DV, Chatlynne LG, Whitman JE, Jr., et al. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev, 15: 439-464, 2002.
20. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol, 70: 549-558, 1996.
21. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA, 93: 14862-14867, 1996.
22. Desrosiers RC, Sasseville VG, Czajak SC, et al. A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol, 71: 9764-9769, 1997.
23. Greensill J, Sheldon JA, Renwick NM, et al. Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? J Virol, 74: 1572-1577, 2000.
24. Lacoste V, Mauclere P, Dubreuil G, et al. Simian homologues of human gamma-2 and betaherpesviruses in mandrill and drill monkeys. J Virol, 74: 11993-11999, 2000.
25. Greensill J, Sheldon JA, Murthy KK, et al. A chimpanzee rhadinovirus sequence related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after HIV-1 infection in the absence of disease. Aids, 14: F129-35, 2000.
26. Lacoste V, Mauclere P, Dubreuil G, et al. KSHV-like herpesviruses in chimps and gorillas. Nature, 407: 151-152, 2000.
27. Renne R, Lagunoff M, Zhong W, et al. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol, 70: 8151-8154, 1996.
28. Wu L, Lo P, Yu X, et al. Three-dimensional structure of the human herpesvirus 8 capsid. J Virol, 74: 9646-9654, 2000.
29. Lagunoff M and Ganem D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology, 236: 147-1454, 1997.
30. Biggar RJ, Whitby D, Marshall V, et al. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis, 181: 1562-1568, 2000.
31. Hayward GS. KSHV strains: the origins and global spread of the virus. Semin Cancer Biol, 9: 187-199, 1999.
32. Kakoola DN, Sheldon J, Byabazaire N, et al. Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene. J Gen Virol, 82: 2393-2404, 2001.
33. Zong JC, Ciufo DM, Alcendor DJ, et al. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol, 73: 4156-4170, 1999.
34. Kasolo FC, Monze M, Obel N, et al. Sequence analyses of human herpesvirus-8 strains from both African human immunodeficiency virus-negative and -positive childhood endemic Kaposi's sarcoma show a close relationship with strains identified in febrile children and high variation in the K1 glycoprotein. J Gen Virol, 79 (Pt 12): 3055-3065, 1998.
35. Zong J, Ciufo DM, Viscidi R, et al. Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol, 23: 119-148, 2002.
36. Bosch ML, Strand KB, Rose TM. Gammaherpesvirus sequence comparisons. J Virol, 72: 8458-8459, 1998.
37. Searles RP, Bergquam EP, Axthelm MK, et al. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/ human herpesvirus 8. J Virol, 73: 3040-3053, 1999.
38. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med, 1: 1274-1278, 1995.
39. Foreman KE, Bacon PE, Hsi ED, et al. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. J Clin Invest, 99: 2971-2978, 1997.
40. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science, 268: 582-583, 1995.
41. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med, 183: 2385-2390, 1996.
42. Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol, 71: 7963-7968, 1997.
43. Kirshner JR, Staskus K, Haase A, et al. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J Virol, 73: 6006-6014, 1999.
44. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA, 96: 4546-4551, 1999.
45. Banks PM and Warnke RA. Primary effusion lymphoma. In: Tumours of the Haematopoietic and Lymphoid Tissues. Ed. Jaffe ES, Harris NL, Stein H and Vardiman JW. IARC Press, Lyon, pp 179-180, 2001.
46. Blackbourn DJ, Lennette E, Klencke B, et al. The restricted cellular host range of human herpesvirus 8. Aids, 14: 1123-1133, 2000.
47. Renne R, Blackbourn D, Whitby D, et al. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol, 72: 5182-5188, 1998.
48. Cerimele F, Curreli F, Ely S, et al. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J Virol, 75: 2435-2443, 2001.
49. Kliche S, Kremmer E, Hammerschmidt W, et al. Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8. J Virol, 72: 8143-8149, 1998.
50. Vieira J, O'Hearn P, Kimball L, et al. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol, 75: 1378-1386, 2001.
51. Flore O, Rafii S, Ely S, et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature, 394: 588-592, 1998.
52. Ciufo DM, Cannon JS, Poole LJ, et al. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol, 75: 5614-5626, 2001.
53. Moses AV, Fish KN, Ruhl R, et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol, 73: 6892-6902, 1999.
54. Lagunoff M, Bechtel J, Venetsanakos E, et al. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J Virol, 76: 2440-2448, 2002.
55. Bechtel JT, Liang Y, Hvidding J, et al. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol, 77: 6474-6481, 2003.
56. Dourmishev LA, Dourmishev AL, Palmeri D, et al. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev, 67: 175-212, 2003.
57. Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med, 4: 435-440, 1998.
58. Lee H, Guo J, Li M, et al. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol, 18: 5219-5228, 1998.
59. Lagunoff M, Majeti R, Weiss A, et al. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA, 96: 5704-5709, 1999.
60. Lee BS, Paulose-Murphy M, Chung YH, et al. Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction. J Virol, 76: 12185-12199, 2002.
61. Lagunoff M, Lukac DM and Ganem D. Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J Virol, 75: 5891-5898, 2001.
62. Prakash O, Tang ZY, Peng X, et al. Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J Natl Cancer Inst, 94: 926-935, 2002.
63. Osborne J, Moore PS and Chang Y. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol, 60: 921-927, 1999.
64. Hideshima T, Chauhan D, Teoh G, et al. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. Clin Cancer Res, 6: 1180-1189, 2000.
65. Klouche M, Brockmeyer N, Knabbe C, et al. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells. Aids, 16: F9-18, 2002.
66. Nicholas J, Ruvolo VR, Burns WH, et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med, 3: 287-292, 1997.
67. Molden J, Chang Y, You Y, et al. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem, 272: 19625-19631, 1997.
68. Mullberg J, Geib T, Jostock T, et al. IL-6 receptor independent stimulation of human gp130 by viral IL-6. J Immunol, 164: 4672-4677, 2000.
69. Wan X, Wang H and Nicholas J. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol, 73: 8268-82678, 1999.
70. Chatterjee M, Osborne J, Bestetti G, et al. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science, 298: 1432-1435, 2002.
71. Liu L, Eby MT, Rathore N, et al. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem, 277: 13745-13751, 2002.
72. Jones KD, Aoki Y, Chang Y, et al. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood, 94: 2871-2879, 1999.
73. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood, 93: 4034-4043, 1999.
74. Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science, 274: 1739-1744, 1996.
75. Zhu FX, Cusano T and Yuan Y. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol, 73: 5556-5567, 1999.
76. Boshoff C, Endo Y, Collins PD, et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science, 278: 290-294, 1997.
77. Endres MJ, Garlisi CG, Xiao H, et al. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J Exp Med, 189: 1993-1998, 1999.
78. Kledal TN, Rosenkilde MM, Coulin F, et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science, 277: 1656-1659, 1997.
79. Haque M, Chen J, Ueda K, et al. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J Virol, 74: 2867-2875, 2000.
80. Dairaghi DJ, Fan RA, McMaster BE, et al. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem, 274: 21569-21574, 1999.
81. Louahed J, Struyf S, Demoulin JB, et al. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I. Eur J Immunol, 33: 494-501, 2003.
82. Stine JT, Wood C, Hill M, et al. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood, 95: 1151-1157, 2000.
83. Wang HW, Sharp TV, Koumi A, et al. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. Embo J, 21: 2602-2615, 2002.
84. Feng P, Park J, Lee BS, et al. Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J Virol, 76: 11491-1504, 2002.
85. Cheng EH, Nicholas J, Bellows DS, et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA, 94: 690-694, 1997.
86. Sarid R, Sato T, Bohenzky RA, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med, 3: 293-298, 1997.
87. Afonso CL, Neilan JG, Kutish GF, et al. An African swine fever virus Bcl-2 homolog, 5-HL, suppresses apoptotic cell death. J Virol, 70: 4858-4863, 1996.
88. Bellows DS, Chau BN, Lee P, et al. Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol, 74: 5024-5031, 2000.
89. Inohara N, Gourley TS, Carrio R, et al. Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death. J Biol Chem, 273: 32479-32486, 1998.
90. Escalante CR, Yie J, Thanos D, et al. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature, 391: 103-106, 1998.
91. Lubyova B and Pitha PM. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol, 74: 8194-8201, 2000.
92. Gao SJ, Boshoff C, Jayachandra S, et al. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene, 15: 1979-1985, 1997.
93. Li M, Lee H, Guo J, et al. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol, 72: 5433-5440, 1998.
94. Burysek L, Yeow WS, Lubyova B, et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol, 73: 7334-7342, 1999.
95. Jayachandra S, Low KG, Thlick AE, et al. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc Natl Acad Sci USA, 96: 11566-11571, 1999.
96. Li M, Damania B, Alvarez X, et al. Inhibition of P300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol, 20: 8254-8263, 2000.
97. Nakamura H, Li M, Zarycki J, et al. Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol, 75: 7572-7582, 2001.
98. Chung YH, Means RE, Choi JK, et al. Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol, 76: 4688-4698, 2002.
99. Arvanitakis L, Geras-Raaka E, Varma A, et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature, 385: 347-350, 1997.
100. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature, 391: 86-89, 1998.
101. Yang TY, Chen SC, Leach MW, et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med, 191: 445-454, 2000.
102. Couty JP, Geras-Raaka E, Weksler BB, et al. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells. J Biol Chem, 276: 33805-33811, 2001.
103. Montaner S, Sodhi A, Pece S, et al. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res, 61: 2641-2648, 2001.
104. Schwarz M and Murphy PM. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol, 167: 505-513, 2001.
105. Pati S, Cavrois M, Guo HG, et al. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol, 75: 8660-8673, 2001.
106. Shepard LW, Yang M, Xie P, et al. Constitutive activation of NF-kappa B and secretion of interleukin-8 induced by the G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus involve G alpha(13) and RhoA. J Biol Chem, 276: 45979-45987, 2001.
107. Sodhi A, Montaner S, Patel V, et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res, 60: 4873-4880, 2000.
108. Rivas C, Thlick AE, Parravicini C, et al. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol, 75: 429-438, 2001.
109. Burysek L, Yeow WS and Pitha PM. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol, 2: 19-32, 1999.
110. Burysek L and Pitha PM. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol, 75: 2345-2352, 2001.
111. Sadler R, Wu L, Forghani B, et al. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol, 73: 5722-5730, 1999.
112. Kliche S, Nagel W, Kremmer E, et al. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol Cell, 7: 833-843, 2001.
113. Muralidhar S, Pumfery AM, Hassani M, et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol, 72: 4980-4988, 1998.
114. Muralidhar S, Veytsmann G, Chandran B, et al. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J Clin Virol, 16: 203-213, 2000.
115. Kolanus W, Nagel W, Schiller B, et al. Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell, 86: 233-242, 1996.
116. Dittmer D, Stoddart C, Renne R, et al. Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J Exp Med, 190: 1857-1868, 1999.
117. Grundhoff A and Ganem D. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J Virol, 75: 1857-1863, 2001.
118. Sarid R, Wiezorek JS, Moore PS, et al. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol, 73: 1438-1446, 1999.
119. Talbot SJ, Weiss RA, Kellam P, et al. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology, 257: 84-94, 1999.
120. Zhang YJ, Deng JH, Rabkin C, et al. Hot-spot variations of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen and application in genotyping by PCR-RFLP. J Gen Virol, 81: 2049-2058, 2000.
121. Radkov SA, Kellam P and Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med, 6: 1121-1127, 2000.
122. Friborg J, Jr., Kong W, Hottiger MO, et al. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature, 402: 889-894, 1999.
123. Platt GM, Simpson GR, Mittnacht S, et al. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol, 73: 9789-9795, 1999.
124. Garber AC, Shu MA, Hu J, et al. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol, 75: 7882-7892, 2001.
125. Krithivas A, Fujimuro M, Weidner M, et al. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J Virol, 76: 11596-11604, 2002.
126. Hu J, Garber AC, Renne R. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol, 76: 11677-11687, 2002.
127. Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science, 284: 641-644, 1999.
128. Cotter MA, 2nd and Robertson ES. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology, 264: 254-264, 1999.
129. Szekely L, Kiss C, Mattsson K, et al. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies. J Gen Virol, 80 (Pt 11): 2889-2900, 1999.
130. Piolot T, Tramier M, Coppey M, et al. Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol, 75: 3948-3959, 2001.
131. Ballestas ME and Kaye KM. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol, 75: 3250-3258, 2001.
132. Garber AC, Hu J, Renne R. Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem. 277: 27401-27411, 2002.
133. Li M, Lee H, Yoon DW, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol, 71: 1984-1991, 1997.
134. Swanton C, Mann DJ, Fleckenstein B, et al. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature, 390: 184-187, 1997.
135. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature, 382: 410, 1996.
136. Card GL, Knowles P, Laman H, et al. Crystal structure of a gamma-herpesvirus cyclin-cdk complex. Embo J, 19: 2877-2888, 2000.
137. Ellis M, Chew YP, Fallis L, et al. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. Embo J, 18: 644-653, 1999.
138. Mann DJ, Child ES, Swanton C, et al. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. Embo J, 18: 654-663, 1999.
139. Laman H, Coverley D, Krude T, et al. Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol Cell Biol, 21: 624-635, 2001.
140. Djerbi M, Screpanti V, Catrina AI, et al. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med, 190: 1025-1032, 1999.
141. Belanger C, Gravel A, Tomoiu A, et al. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. J Hum Virol, 4: 62-73, 2001.
142. Thome M, Schneider P, Hofmann K, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature, 386: 517-521, 1997.
143. Sharp TV, Wang HW, Koumi A, et al. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol, 76: 802-8162, 2002.
144. Glenn M, Rainbow L, Aurade F, et al. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol, 73: 6953-6963, 1999.
145. Poole LJ, Zong JC, Ciufo DM, et al. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol, 73: 6646-6660, 1999.
146. Chan AC, Chan JK, Yan KW, et al. Anaplastic large cell lymphoma presenting as a pleural effusion and mimicking primary effusion lymphoma. A report of 2 cases. Acta Cytol, 47: 809-8016, 2003.
147. Schulz TF. KSHV/HHV8-associated lymphoproliferations in the AIDS setting. Eur J Cancel, 37: 1217-1226, 2001.
148. Said JW, Shintaku IP, Asou H, et al. Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Arch Pathol Lab Med, 123: 257-260, 1999.
149. Capello D, Gaidano G, Gallicchio M, et al. The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. Leukemia, 14: 285-291, 2000.
150. Jones D, Ballestas ME, Kaye KM, et al. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med, 339: 444-449, 1998.
151. Dotti G, Fiocchi R, Motta T, et al. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia, 13: 664-670, 1999.
152. Nador RG, Cesarman E, Knowles DM, et al. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N Engl J Med, 333: 943, 1995.
153. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood, 88: 3124-3128, 1996.
154. Strauchen JA, Hauser AD, Burstein D, et al. Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med, 125: 822-825, 1996.
155. Okada T, Katano H, Tsutsumi H, et al. Body-cavity-based lymphoma in an elderly AIDS-unrelated male. Int J Hematol, 67: 417-422, 1998.
156. Cobo F, Hernandez S, Hernandez L, et al. Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient. J Pathol, 189: 288-293, 1999.
157. Ascoli V, Scalzo CC, Danese C, et al. Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men. Eur Respir J, 14: 1231-1234, 1999.
158. Klepfish A, Sarid R, Shtalrid M, et al. Primary effusion lymphoma (PEL) in HIV-negative patients - A distinct clinical entity. Leuk Lymphoma, 41: 439-443, 2001.
159. Cesarman E, Moore PS, Rao PH, et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood, 86: 2708-2714, 1995.
160. Carbone A, Cilia AM, Gloghini A, et al. Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8. Br J Haematol, 102: 1081-1089, 1998.
161. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/ HHV-8) in the absence of Epstein-Barr virus. Blood, 88: 2648-2654, 1996.
162. Horenstein MG, Nador RG, Chadburn A, et al. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/-human herpesvirus-8. Blood, 90: 1186-1191, 1997.
163. Szekely L, Chen F, Teramoto N, et al. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. J Gen Virol, 79 (Pt 6): 1445-1452, 1998.
164. Krithivas A, Young DB, Liao G, et al. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol, 74: 9637-9645, 2000.
165. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood, 88: 645-656, 1996.
166. Gaidano G, Capello D, Cilia AM, et al. Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer, 24: 16-23, 1999.
167. Drexler HG, Uphoff CC, Gaidano G, et al. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia, 12: 1507-1517, 1998.
168. DePond W, Said JW, Tasaka T, et al. Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol, 21: 719-724, 1997.
169. Beaty MW, Kumar S, Sorbara L, et al. A biophenotypic human herpesvirus 8-associated primary bowel lymphoma. Am J Surg Pathol, 23: 992-994, 1999.
170. Costes V, Faumont N, Cesarman E, et al. Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma. Hum Pathol, 33: 846-849, 2002.
171. Navarro JT, Ribera JM, Junca J, et al. Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient. Hum Pathol, 34: 630, 2003.
172. Hollingsworth HC, Stetler-Stevenson M, Gagneten D, et al. Immunodeficiency-associated malignant lymphoma. Three cases showing genotypic evidence of both T- and B-cell lineages. Am J Surg Pathol, 18: 1092-1101, 1994.
173. Lechapt-Zalcman E, Challine D, Delfau-Larue MH, et al. Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man. Arch Pathol Lab Med, 125: 1246-1248, 2001.
174. Matolcsy A, Nador RG, Cesarman E, et al. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol, 153: 1609-1614, 1998.
175. Fais F, Gaidano G, Capello D, et al. Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia, 13: 1093-9, 1999.
176. Elenius K, Salmivirta M, Inki P, et al. Binding of human syndecan to extracellular matrix proteins. J Biol Chem, 265: 17837-17843, 1990.
177. Carbone A, Gloghini A, Cozzi MR, et al. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br J Haematol, 111: 247-257, 2000.
178. Gaidano G and Carbone A. MUM1: a step ahead toward the understanding of lymphoma histogenesis. Leukemia, 14: 563-566, 2000.
179. Tsuboi K, Iida S, Inagaki H, et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia, 14: 449-456, 2000.
180. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood, 97: 744-751, 2001.
181. Klein U, Gloghini A, Gaidano G, et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood, 101: 4115-4121, 2003.
182. Jenner RG, Maillard K, Cattini N, et al. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci USA, 100: 10399-10404, 2003.
183. Knowles DM, Inghirami G, Ubriaco A, et al. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood, 73: 792-799, 1989.
184. Walts AE, Shintaku IP, Said JW. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol, 94: 170-175, 1990.
185. Picchio GR, Sabbe RE, Gulizia RJ, et al. The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology, 238: 22-29, 1997.
186. Boshoff C, Gao SJ, Healy LE, et al. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood, 91: 1671-1679, 1998.
187. Zhong W, Wang H, Herndier B, et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA, 93: 6641-6646, 1996.
188. Parravicini C, Chandran B, Corbellino M, et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol, 156: 743-749, 2000.
189. Katano H, Sato Y, Kurata T, et al. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology, 269: 335-344, 2000.
190. Carbone A, Gloghini A, Bontempo D, et al. Proliferation in HHV-8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1). Am J Pathol, 156: 1209-1215, 2000.
191. Cannon JS, Ciufo D, Hawkins AL, et al. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol, 74: 10187-10193, 2000.
192. Morand P, Buisson M, Collandre H, et al. Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient. Leuk Lymphoma, 35: 379-387, 1999.
193. Cannon JS, Nicholas J, Orenstein JM, et al. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis, 180: 824-828, 1999.
194. Staskus KA, Sun R, Miller G, et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol, 73: 4181-4187, 1999.
195. Aoki Y, Yarchoan R, Braun J, et al. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood, 96: 1599-1601, 2000.
196. Asou H, Said JW, Yang R, et al. Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood, 91: 2475-2481, 1998.
197. Aoki Y and Tosato G. Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood, 94: 4247-4254, 1999.
198. Frizzera G. Castleman's disease: more questions than answers. Hum Pathol, 16: 202-205, 1985.
199. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol, 5: 525-530, 1992.
200. Amin HM, Medeiros LJ, Manning JT, et al. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease. Am J Surg Pathol, 27: 91-100, 2003.
201. Du MQ, Liu H, Diss TC, et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood, 97: 2130-2136, 2001.
202. Grandadam M, Dupin N, Calvez V, et al. Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis, 175: 1198-1201, 1997.
203. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood, 96: 2069-2073, 2000.
204. Oksenhendler E, Cazals-Hatem D, Schulz TF, et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med, 338: 1585-1590, 1998.
205. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood, 90: 2826-2829, 1997.
206. Beck JT, Hsu SM, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal antiinterleukin-6 antibody. N Engl J Med, 330: 602-605, 1994.
207. Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood, 95: 56-61, 2000.
208. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood, 95: 1406-1412, 2000.
209. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood, 99: 2331-2336, 2002.
210. Said JW, Rettig MR, Heppner K, et al. Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood, 90: 4278-4282, 1997.
211. Brousset P, Meggetto F, Attal M, et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science, 278: 1972; author reply 1972-1973, 1997.
212. Agbalika F, Mariette X, Marolleau JP, et al. Detection of human herpesvirus-8 DNA in bone marrow biopsies from patients with multiple myeloma and Waldenstrom's macroglobulinemia. Blood, 91: 4393-4394, 1998.
213. Chauhan D, Bharti A, Raje N, et al. Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells. Blood, 93: 1482-1486, 1999.
214. Raje N, Gong J, Chauhan D, et al. Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences. Blood, 93: 1487-1495, 1999.
215. Beksac M, Ma M, Akyerli C, et al. Frequent demonstration of human herpesvirus 8 (HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM). Leukemia, 15: 1268-1273, 2001.
216. Parravicini C, Lauri E, Baldini L, et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science, 278: 1969-70; author reply 1972-1973, 1997.
217. Masood R, Zheng T, Tupule A, et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science, 278: 1970-1971; author reply 1972-3, 1997.
218. Bouscary D, Dupin N, Fichelson S, et al. Lack of evidence of an association between HHV-8 and multiple myeloma. Leukemia, 12: 1840-1841, 1998.
219. Cathomas G, Stalder A, Kurrer MO, et al. Multiple myeloma and HHV8 infection. Blood, 91: 4391-4393, 1998.
220. Mitterer M, Mair W, Gatti D, et al. Dendritic cells derived from bone marrow and CD34+ selected blood progenitor cells of myeloma patients, cultured in serum-free media, do not contain the Kaposi sarcoma herpesvirus genome. Br J Haematol, 102: 1338-1340, 1998.
221. Perna AM, Viviano E, Iannitto E, et al. No association between human herpesvirus type 8 infection and multiple myeloma. J Natl Cancer Inst, 90: 1013-1014, 1998.
222. Yi Q, Ekman M, Anton D, et al. Blood dendritic cells from myeloma patients are not infected with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8). Blood, 92: 402-404, 1998.
223. Pan L, Milligan L, Michaeli J, et al. Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn, 3: 32-38, 2001.
224. Hermouet S, Sutton CA, Rose TM, et al. Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia, 17: 185-195, 2003.
225. Gao SJ, Alsina M, Deng JH, et al. Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma. J Infect Dis, 178: 846-849, 1998.
226. Whitby D, Boshoff C, Luppi M, et al. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science, 278: 1971-1972; author reply 1972-1973, 1997.
227. MacKenzie J, Sheldon J, Morgan G, et al. HHV-8 and multiple myeloma in the UK. Lancet, 350: 1144-1145, 1997.
228. Marcelin AG, Dupin N, Bouscary D, et al. HHV-8 and multiple myeloma in France. Lancet, 350: 1144, 1997.
229. Santarelli R, Angeloni A, Farina A, et al. Lack of serologic association between human herpesvirus-8 infection and multiple myeloma and monoclonal gammopathies of undetermined significance. J Natl Cancer Inst, 90: 781-782, 1998.
230. Brander C, Raje N, O'Connor PG, et al. Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma. Blood, 100: 698-700, 2002.
231. Cottoni F and Uccini S. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science, 278: 1972; author reply 1972-1973, 1997.
232. Ablashi DV, Chatlynne L, Thomas D, et al. Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma. Blood, 96: 2304-2306, 2000.
233. Tedeschi R, Kvarnung M, Knekt P, et al. A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma. Br J Cancer, 84: 122-125, 2001.
234. Tisdale JF, Stewart AK, Dickstein B, et al. Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected. Blood, 92: 2681-2687, 1998.
235. Ma HJ, Sjak-Shie NN, Vescio RA, et al. Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma. Clin Cancer Res, 6: 4226-4233, 2000.
236. Dominici M, Luppi M, Campioni D, et al. PCR with degenerate primers for highly conserved DNA polymeras e gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients. Int J Cancer, 86: 76-82, 2000.
237. Agbalika F, Marolleau JP and Brouet JC. Interleukin-6 stimulates HHV-8 replication in bone marrow cultures and infected cell lines. Hematol J, 1: 48-52, 2000.
238. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood, 87: 3903-3909, 1996.
239. Trovato R, Luppi M, Barozzi P, et al. Cellular localization of human herpesvirus 8 in non-neoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies. J Hum Virol, 2: 38-44, 1999.
240. Nador RG, Chadburn A, Gundappa G, et al. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol, 27: 293-302, 2003.
241. Du MQ, Diss TC, Liu H, et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood, 100: 3415-3418, 2002.